Annoroad

Recent Finacing

Series C

Recent Raise

$105M

Annoroad develops and manufactures high-throughput gene sequencers and reagents, provides NGS-based clinical and research testing (reproductive, disease, tumor, genetic screening), and operates sequencing services and a cloud genomics platform.